JDRF Blog

Recent Articles

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • JDRF Clinical Trial Results Announced at the 55th EASD Meeting

    September 18, 2019

    A protein, called glucokinase (or GK), acts as a key regulator of sugar levels in the body. If blood glucose levels are...

  • FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia

    September 11, 2019

    “The approval of the GVOKE HypoPenTM is an important step forward for people with diabetes. Severe hypoglycemia is a terrifying and dangerous...

  • Semma Therapeutics, Backed by the JDRF T1D Fund, Acquired by Major Biopharma Company

    September 4, 2019

    In an exciting step forward in type 1 diabetes (T1D) research and development and for people with T1D, on September 3, 2019,...

  • JDRF Innovative Clinical Trial Design Workshop

    August 27, 2019

    BMC Medicine 16: 29 (2018)

  • The Type 1 Diabetes Digital Recipe Box

    August 14, 2019

    When you’re cooking to meet the needs of someone with type 1 diabetes (T1D), whether that be yourself, a family member or...